Does Dr. MOHAMMED ALJASMI have financial conflicts of interest?

Dr. MOHAMMED ALJASMI (M.D.) has received a total of $200 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $200 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MOHAMMED ALJASMI?

According to CMS Open Payments data, Dr. MOHAMMED ALJASMI received funding from PULMONX CORPORATION ($93), UNITED THERAPEUTICS CORPORATION ($77), and GLAXOSMITHKLINE ($16).

Does Dr. MOHAMMED ALJASMI receive research grants or speaking fees?

Dr. MOHAMMED ALJASMI has received $200 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MOHAMMED ALJASMI

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Pulmonary Disease

Practice Location: HUNTINGTON, WV 25701

NPI Number: 1821376807

LIFETIME INDUSTRY VALUE

$200

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALJASMI is a verified Internal Medicine, Pulmonary Disease practitioner based in HUNTINGTON, WV.

Between 2021 and 2024, Dr. ALJASMI had an overall industry promotional and research financial footprint of $200 as recorded in the federal CMS Open Payments database.

$200 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALJASMI's primary funding source is PULMONX CORPORATION, which accounts for $93 (representing 46.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PULMONX CORPORATION

Rank 1

$93

46.6%

UNITED THERAPEUTICS CORPORATION

Rank 2

$77

38.5%

GLAXOSMITHKLINE

Rank 3

$16

8.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.